Walvax BioTech (300142) — Long-term Investment Intensity
Walvax BioTech (300142) has a Long-term Investment Intensity of 12.3% as of December 2019. Long-term investments of CN¥862.27 Million represent 12.3% of total assets of CN¥7.02 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 300142 financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Walvax BioTech Long-term Investment Intensity (2015–2019)
This chart shows how Walvax BioTech's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 12.3%, reflecting long-term investments of CN¥862.27 Million against total assets of CN¥7.02 Billion CNY. For the complete balance sheet picture, see Walvax BioTech asset portfolio.
Annual Long-term Investment Intensity for Walvax BioTech (2015–2019)
The table below presents the year-by-year Long-term Investment Intensity for Walvax BioTech from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Walvax BioTech debt and liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 12.3% | CN¥862.27 Million | CN¥7.02 Billion | ▲ +1.9 pp |
| 2018 | 10.4% | CN¥751.56 Million | CN¥7.24 Billion | ▲ +4.8 pp |
| 2017 | 5.6% | CN¥326.89 Million | CN¥5.88 Billion | ▲ +0.3 pp |
| 2016 | 5.3% | CN¥335.51 Million | CN¥6.32 Billion | ▼ -6.2 pp |
| 2015 | 11.5% | CN¥721.86 Million | CN¥6.26 Billion | — |